Customer-submitted results

Videos sent in by customers and published with their permission. We have not edited the footage.

Individual experiences. They are not typical results, not clinical evidence and not a claim about what any product will do. Compounds sold by US Peptide Labs are for laboratory research use only.

📉 Interactive · trial data

48 weeks, one curve ⏱️

Drag the slider or press play. The shape follows the average change reported for the top dose in the published 48-week triple-agonist study.

-17.5%average change

42 lbdown from 240 lb

198 lbat week 24

Week of study 24 / 48

012243648

Starting weight (lb)

Published points: -17.5% at week 24 and -24.2% at week 48 (12 mg group, NEJM 2023). Values in between are interpolated. Trial averages in supervised participants, not a prediction for any person.

Week 24

-17.5% avg

- - start outline